Nargiza Parpieva

Eng koʻp iqtibos qilingan asarlar

1. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis20228 iqtibos
2. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study20154 iqtibos
3. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20164 iqtibos
4. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan20224 iqtibos
5. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan20163 iqtibos
6. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan20203 iqtibos
7. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?20213 iqtibos
8. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan20162 iqtibos
9. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–201820212 iqtibos
10. Effectiveness and Safety of a Shorter Treatment Regimen in a Setting with a High Burden of Multidrug-Resistant Tuberculosis20212 iqtibos

Hammualliflar

1. Jamshid Gadoev17 ta umumiy asar2015–2021
2. Irina Liverko10 ta umumiy asar2021–2025
3. Jay Achar10 ta umumiy asar2015–2024
4. Zinaida Tigay9 ta umumiy asar2015–2025
5. Khasan Safaev9 ta umumiy asar2014–2025
6. Philipp du Cros9 ta umumiy asar2015–2022
7. Ruzilya Usmanova7 ta umumiy asar2021–2025
8. Arax Hovhannesyan5 ta umumiy asar2021–2024
9. Barno Abdusamatova5 ta umumiy asar2021
10. Sevak Alaverdyan5 ta umumiy asar2021

Barcha hammualliflar →